Curcumin inhibits the glycolytic activity of tumor cells by inhibiting the expression and activity of HK2 in HCT116 and HT29 cells, and induces the dissociation of mitochondrial HK2 through AKT phosphorylation, leading to mitochondria-mediated apoptosis [24]. The gene discussed is AKT1; the disease is neoplasm.